IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on April 30, 2018. The filing serves to announce the Company's financial results for the first quarter ended March 31, 2018. The Company is incorporated in Delaware and identifies as an emerging growth company.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references a press release (Exhibit 99.1) containing these details but does not reproduce the figures within the body of the 8-K text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release detailing the first-quarter results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or contingencies. It notes that the information in Item 2.02 and the attached exhibit is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 30, 2018) for specific Q1 2018 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Check subsequent filings for any updates to the financial results announced in this report.